Stay updated on IMU-131 HER-Vaxx in HER2+ Gastric Cancer Clinical Trial
Sign up to get notified when there's something new on the IMU-131 HER-Vaxx in HER2+ Gastric Cancer Clinical Trial page.

Latest updates to the IMU-131 HER-Vaxx in HER2+ Gastric Cancer Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedA new revision entry (v3.6.6) was added to the study history, superseding v3.6.5. This update concerns the record's metadata rather than any substantive changes to the study content or results.SummaryDifference0.1%

- Check27 days agoNo Change Detected
- Check41 days agoChange DetectedDifference0.1%

- Check55 days agoChange DetectedThe record history now shows a new Revision tag, v3.6.4, replacing the previous v3.6.3, indicating a small software update to the page rather than changes to the study data.SummaryDifference0.1%

- Check76 days agoChange DetectedA new revision entry, Revision: v3.6.3, was added to the study record history, replacing the previous Revision: v3.6.2. This is a metadata update to the page’s version history.SummaryDifference0.1%

- Check84 days agoChange DetectedA new revision label v3.6.2 was added and the previous v3.6.0 removed in the study history. This indicates a newer saved version of the record.SummaryDifference0.1%

- Check98 days agoChange DetectedThe recruitment status was updated to indicate enrollment has closed, and a new document revision (v3.6.0) was added while the previous revision (v3.5.5) was removed.SummaryDifference0.3%

Stay in the know with updates to IMU-131 HER-Vaxx in HER2+ Gastric Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IMU-131 HER-Vaxx in HER2+ Gastric Cancer Clinical Trial page.